These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

526 related items for PubMed ID: 19544166

  • 1. A randomized study comparing the effect of loratadine added to montelukast with montelukast, loratadine, and beclomethasone monotherapies in patients with chronic asthma.
    Lu S, Liu N, Dass SB, Reiss TF.
    J Asthma; 2009 Jun; 46(5):465-9. PubMed ID: 19544166
    [Abstract] [Full Text] [Related]

  • 2. Clinical studies of combination montelukast and loratadine in patients with seasonal allergic rhinitis.
    Lu S, Malice MP, Dass SB, Reiss TF.
    J Asthma; 2009 Nov; 46(9):878-83. PubMed ID: 19905912
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and tolerability of montelukast alone or in combination with loratadine in seasonal allergic rhinitis: a multicenter, randomized, double-blind, placebo-controlled trial performed in the fall.
    Nayak AS, Philip G, Lu S, Malice MP, Reiss TF, Montelukast Fall Rhinitis Investigator Group.
    Ann Allergy Asthma Immunol; 2002 Jun; 88(6):592-600. PubMed ID: 12086367
    [Abstract] [Full Text] [Related]

  • 4. The efficacy of montelukast during the allergy season in pediatric patients with persistent asthma and seasonal aeroallergen sensitivity.
    Papadopoulos NG, Philip G, Giezek H, Watkins M, Smugar SS, Polos PG.
    J Asthma; 2009 May; 46(4):413-20. PubMed ID: 19484680
    [Abstract] [Full Text] [Related]

  • 5. Comparison of the combinations of fexofenadine-pseudoephedrine and loratadine-montelukast in the treatment of seasonal allergic rhinitis.
    Moinuddin R, deTineo M, Maleckar B, Naclerio RM, Baroody FM.
    Ann Allergy Asthma Immunol; 2004 Jan; 92(1):73-9. PubMed ID: 14756468
    [Abstract] [Full Text] [Related]

  • 6. Oral montelukast versus inhaled beclomethasone in 6- to 11-year-old children with asthma: results of an open-label extension study evaluating long-term safety, satisfaction, and adherence with therapy.
    Maspero JF, Dueñas-Meza E, Volovitz B, Pinacho Daza C, Kosa L, Vrijens F, Leff JA.
    Curr Med Res Opin; 2001 Jan; 17(2):96-104. PubMed ID: 11759189
    [Abstract] [Full Text] [Related]

  • 7. Concomitant montelukast and loratadine as treatment for seasonal allergic rhinitis: a randomized, placebo-controlled clinical trial.
    Meltzer EO, Malmstrom K, Lu S, Prenner BM, Wei LX, Weinstein SF, Wolfe JD, Reiss TF.
    J Allergy Clin Immunol; 2000 May; 105(5):917-22. PubMed ID: 10808172
    [Abstract] [Full Text] [Related]

  • 8. Montelukast added to inhaled beclomethasone in treatment of asthma. Montelukast/Beclomethasone Additivity Group.
    Laviolette M, Malmstrom K, Lu S, Chervinsky P, Pujet JC, Peszek I, Zhang J, Reiss TF.
    Am J Respir Crit Care Med; 1999 Dec; 160(6):1862-8. PubMed ID: 10588598
    [Abstract] [Full Text] [Related]

  • 9. Efficacy and tolerability of salmeterol/fluticasone propionate versus montelukast in childhood asthma: A prospective, randomized, double-blind, double-dummy, parallel-group study.
    Maspero J, Guerra F, Cuevas F, Gutierrez JP, Soto-Ramos M, Anderton S, Mechali D, Chan R, Pedersen S.
    Clin Ther; 2008 Aug; 30(8):1492-504. PubMed ID: 18803991
    [Abstract] [Full Text] [Related]

  • 10. Adherence with montelukast or fluticasone in a long-term clinical trial: results from the mild asthma montelukast versus inhaled corticosteroid trial.
    Rand C, Bilderback A, Schiller K, Edelman JM, Hustad CM, Zeiger RS, MIAMI Study Research Group.
    J Allergy Clin Immunol; 2007 Apr; 119(4):916-23. PubMed ID: 17349681
    [Abstract] [Full Text] [Related]

  • 11. Fluticasone propionate/salmeterol combination compared with montelukast for the treatment of persistent asthma.
    Pearlman DS, White MV, Lieberman AK, Pepsin PJ, Kalberg C, Emmett A, Bowers B, Rickard KA, Dorinsky P.
    Ann Allergy Asthma Immunol; 2002 Feb; 88(2):227-35. PubMed ID: 11868930
    [Abstract] [Full Text] [Related]

  • 12. A randomized placebo-controlled study of intravenous montelukast for the treatment of acute asthma.
    Camargo CA, Gurner DM, Smithline HA, Chapela R, Fabbri LM, Green SA, Malice MP, Legrand C, Dass SB, Knorr BA, Reiss TF.
    J Allergy Clin Immunol; 2010 Feb; 125(2):374-80. PubMed ID: 20159247
    [Abstract] [Full Text] [Related]

  • 13. Efficacy of montelukast during the allergy season in patients with chronic asthma and seasonal aeroallergen sensitivity.
    Busse WW, Casale TB, Dykewicz MS, Meltzer EO, Bird SR, Hustad CM, Grant E, Zeldin RK, Edelman JM.
    Ann Allergy Asthma Immunol; 2006 Jan; 96(1):60-8. PubMed ID: 16440534
    [Abstract] [Full Text] [Related]

  • 14. Clinical studies of the DP1 antagonist laropiprant in asthma and allergic rhinitis.
    Philip G, van Adelsberg J, Loeys T, Liu N, Wong P, Lai E, Dass SB, Reiss TF.
    J Allergy Clin Immunol; 2009 Nov; 124(5):942-8.e1-9. PubMed ID: 19748656
    [Abstract] [Full Text] [Related]

  • 15. Montelukast in asthmatic patients 6 years-14 years old with an FEV1 > 75%.
    Becker A, Swern A, Tozzi CA, Yu Q, Reiss T, Knorr B.
    Curr Med Res Opin; 2004 Oct; 20(10):1651-9. PubMed ID: 15462699
    [Abstract] [Full Text] [Related]

  • 16. Low-dose fluticasone propionate compared with montelukast for first-line treatment of persistent asthma: a randomized clinical trial.
    Busse W, Raphael GD, Galant S, Kalberg C, Goode-Sellers S, Srebro S, Edwards L, Rickard K, Fluticasone Proprionate Clinical Research Study Group.
    J Allergy Clin Immunol; 2001 Mar; 107(3):461-8. PubMed ID: 11240946
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [A fixed combination of fluticasone and salmeterol permits better control of asthma than a beclomethasone dipropionate and montelukast combination].
    Grosclaude M, Cerruti JL, Delannay B, Hérent M, Spilthooren F, Desfougères JL.
    Eur Ann Allergy Clin Immunol; 2003 Nov; 35(9):356-62. PubMed ID: 14716965
    [Abstract] [Full Text] [Related]

  • 19. Montelukast, a leukotriene receptor antagonist, in combination with loratadine, a histamine receptor antagonist, in the treatment of chronic asthma.
    Reicin A, White R, Weinstein SF, Finn AF, Nguyen H, Peszek I, Geissler L, Seidenberg BC.
    Arch Intern Med; 2000 Sep 11; 160(16):2481-8. PubMed ID: 10979060
    [Abstract] [Full Text] [Related]

  • 20. Montelukast, compared with fluticasone, for control of asthma among 6- to 14-year-old patients with mild asthma: the MOSAIC study.
    Garcia Garcia ML, Wahn U, Gilles L, Swern A, Tozzi CA, Polos P.
    Pediatrics; 2005 Aug 11; 116(2):360-9. PubMed ID: 16061590
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.